Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer.

Cancer research - 1 Apr 2002

Li Zheng, Meng Zhen Hang, Chandrasekaran Raman, Kuo Wen-Lin, Collins Colin C, Gray Joe W, Dairkee Shanaz H

Abstract excerpt

Loss of heterozygosity within the short arm of chromosome 3 is a common molecular event in several types of solid tumors. In breast cancer, 3p loss of heterozygosity occurs in invasive tumor cells as well as in morphologically normal terminal ductal lobular units adjacent to carcinoma in some cases [G. Deng et al., Science (Wash. DC), 274: 2057-2059, 1996.]. The most frequent region of allelic loss at 3p24.3 in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ductal, Breast
Share to Gene Dosage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Silencing

Share to Loss of Heterozygosity

Share to Neoplasm Staging

Share to Receptors, Thyroid Hormone

Share to Thyroid Hormone Receptors beta

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 11929806

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer.PMID 11929806Read ↗

High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss.Semantic proximity Read ↗

Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological featuresSemantic proximity Read ↗

The loss of estrogen and progesterone receptor gene expression in human breast cancer.Semantic proximity Read ↗

Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q.Semantic proximity Read ↗

Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer.Semantic proximity Read ↗

Loss of LRIG1 locus increases risk of early and late relapse of stage I/II breast cancer.Semantic proximity Read ↗

Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas.Semantic proximity Read ↗

Allelic loss on chromosome 1p is Associated with progression and lymph node metastasis of primary breast carcinomaSemantic proximity Read ↗

Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients.Semantic proximity Read ↗

Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas.Semantic proximity Read ↗

Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer.Semantic proximity Read ↗

Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.